EcoDrugPlus

Ensembl ID : ENSCSAVG00000000352
Gene Symbol: -
1 Cross references
462 Possible Orthologues:

Ensembl ID : ENSCSAVG00000000425
Gene Symbol: -
1 Cross references
274 Possible Orthologues:

Ensembl ID : ENSCSAVG00000000436
Gene Symbol: -
1 Cross references
491 Possible Orthologues:

Ensembl ID : ENSCSAVG00000000511
Gene Symbol: -
1 Cross references
207 Possible Orthologues:

Ensembl ID : ENSCSAVG00000000818
Gene Symbol: -
1 Cross references
432 Possible Orthologues:

Ensembl ID : ENSCSAVG00000000937
Gene Symbol: -
1 Cross references
292 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001000
Gene Symbol: -
1 Cross references
295 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001036
Gene Symbol: -
1 Cross references
228 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001147
Gene Symbol: -
1 Cross references
225 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001227
Gene Symbol: -
1 Cross references
209 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001240
Gene Symbol: -
1 Cross references
305 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001345
Gene Symbol: -
1 Cross references
1213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).